Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Jordi Bruix(Hospital Clínic de Barcelona), Juan Rodés(Hospital Clínic de Barcelona), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Riccardo Lencioni(University of Pisa), Andrew K. Burroughs(University College London), Michel Beaugrand(Hôpital Jean-Verdier), Massimo Colombo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Erik Christensen(Rigshospitalet), Luigi Pagliaro(St James's University Hospital), Morris Sherman(University Health Network)
Cited by 4,079
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
|Gastroenterology|2016|1.8k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k